Autoimmune Diseases  >>  MIS416  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MIS416 / Amplia Therap
NCT02228213: Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis

Completed
2b
93
RoW
MIS416, Saline, Placebo
Innate Immunotherapeutics, Syneos Health
Secondary Progressive Multiple Sclerosis
05/17
06/17
NCT01191996: Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis

Completed
1/2
34
RoW
MIS416
Innate Immunotherapeutics, Primorus Clinical Trials, National Multiple Sclerosis Society
Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis
06/12
11/12

Download Options